skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO

Clinical neuroradiology (Munich), 2023-03, Vol.33 (1), p.155-160 [Peer Reviewed Journal]

COPYRIGHT 2023 Springer ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022. ;ISSN: 1869-1439 ;EISSN: 1869-1447 ;DOI: 10.1007/s00062-022-01196-5

Full text available

Citations Cited by
  • Title:
    Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO
  • Author: Kashani, Nima ; Cimflova, Petra ; Ospel, Johanna M ; Kappelhof, Manon ; Singh, Nishita ; McDonough, Rosalie V ; Almekhlafi, Mohammed A
  • Subjects: Clinical medicine
  • Is Part Of: Clinical neuroradiology (Munich), 2023-03, Vol.33 (1), p.155-160
  • Description: Background Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale. Methods We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions. Results A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was "awaiting better tools" (9/28 responses, 32.1%), while "awaiting better evidence" (8/26 responses, 30.8%), and the need for improved "funding" (7/26 responses, 26.9%) were important barriers in Europe. Conclusion The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.
  • Publisher: Heidelberg: Springer
  • Language: English
  • Identifier: ISSN: 1869-1439
    EISSN: 1869-1447
    DOI: 10.1007/s00062-022-01196-5
  • Source: AUTh Library subscriptions: ProQuest Central

Searching Remote Databases, Please Wait